When Capecitabine Isn't Available: Your Options

Being told your pharmacy can't fill your Capecitabine prescription is alarming — especially when you're in the middle of cancer treatment. Gaps in chemotherapy can affect outcomes, so it's natural to feel anxious about what comes next.

The important thing to know: alternatives do exist. Your oncologist has options, and no ethical cancer doctor will leave you without treatment just because one medication is temporarily hard to find. But understanding those alternatives can help you have a more informed conversation with your care team.

Before we talk about what else is out there, let's quickly cover what Capecitabine is and why your doctor chose it in the first place.

What Is Capecitabine?

Capecitabine (brand name Xeloda) is an oral chemotherapy drug in the fluoropyrimidine class. It's FDA-approved for treating:

• Metastatic breast cancer
• Colon cancer (adjuvant treatment after surgery)
• Metastatic colorectal cancer
• Gastric (stomach) cancer
• Pancreatic cancer
• Esophageal cancer

It comes in 150 mg and 500 mg tablets and is taken twice daily for 14 days followed by 7 days off in a 21-day cycle. For a full overview, read What Is Capecitabine? Uses, Dosage, and What You Need to Know.

How Does Capecitabine Work?

Capecitabine is a prodrug — it's inactive when you swallow it. Your body converts it through a three-step process into 5-fluorouracil (5-FU), which is the compound that actually fights cancer. The clever part: the final conversion step happens more in tumor tissue than in healthy tissue, thanks to an enzyme called thymidine phosphorylase that's concentrated in tumors.

Once activated, 5-FU blocks an enzyme called thymidylate synthase, which cancer cells need to make DNA and divide. Without it, the cancer cells can't replicate.

For a deeper explanation, see How Does Capecitabine Work? Mechanism of Action Explained.

Understanding this mechanism matters because the alternatives listed below all work in related ways — they target the same metabolic pathway in cancer cells.

Alternative 1: Intravenous 5-Fluorouracil (5-FU)

This is the most direct alternative to Capecitabine because 5-FU is literally what Capecitabine turns into in your body. IV 5-FU has been used in cancer treatment for decades and remains a cornerstone of colorectal, breast, and GI cancer therapy.

How it's given: Through an intravenous line, usually at a cancer center or infusion clinic. Depending on your regimen, you might receive it as a bolus (quick push) or as a continuous infusion over 24–48 hours via a portable pump.

Pros:

• Same active drug, proven equivalent efficacy for many cancers
• Well-established dosing protocols
• Generally available even during oral drug shortages

Cons:

• Requires visits to an infusion center (no home dosing)
• May need a surgically placed port or PICC line
• More time-intensive than taking pills at home

Best for: Patients who need to continue fluoropyrimidine-based therapy immediately and can access an infusion center.

Alternative 2: Trifluridine/Tipiracil (Lonsurf)

Lonsurf is an oral combination drug containing trifluridine (an antimetabolite) and tipiracil (which prevents the rapid breakdown of trifluridine). It's FDA-approved for metastatic colorectal cancer and metastatic gastric cancer in patients who've already tried other treatments.

How it's taken: Oral tablets, twice daily on days 1–5 and 8–12 of each 28-day cycle.

Pros:

• Oral medication — taken at home like Capecitabine
• FDA-approved for colorectal and gastric cancers
• Different mechanism that may work even after 5-FU-based treatments have stopped working

Cons:

• Not a direct substitute — it's typically used as a later-line therapy, not as first-line treatment
• Different side effect profile (more myelosuppression)
• Higher cost than generic Capecitabine

Best for: Patients with metastatic colorectal or gastric cancer who have progressed on prior therapies, or when Capecitabine is unavailable and the oncologist determines Lonsurf is clinically appropriate.

Alternative 3: Tegafur/Gimeracil/Oteracil (S-1)

S-1 is an oral fluoropyrimidine combination widely used in Asia and Europe for gastric, colorectal, and other GI cancers. It combines tegafur (a 5-FU prodrug) with two modulators: gimeracil (which slows 5-FU breakdown) and oteracil (which reduces GI toxicity).

How it's taken: Oral capsules, typically twice daily for 28 days followed by a 14-day rest in a 42-day cycle (though schedules vary by regimen).

Pros:

• Oral fluoropyrimidine with extensive clinical data
• May cause less hand-foot syndrome than Capecitabine
• Well-studied in gastric and pancreatic cancer

Cons:

• Not FDA-approved in the United States (used more extensively in Japan, South Korea, and parts of Europe)
• Access may require special arrangements or clinical trials in the U.S.
• Different toxicity profile, particularly regarding myelosuppression

Best for: Patients who may have access through clinical trials or international channels, particularly for gastric or pancreatic cancer.

Alternative 4: Tegafur/Uracil (UFT)

UFT is another oral fluoropyrimidine combination that pairs tegafur with uracil to maintain higher 5-FU levels. It's approved in several countries (not the U.S.) for colorectal cancer and is often given with leucovorin.

How it's taken: Oral capsules, typically three times daily for 28 days in a 35-day cycle.

Pros:

• Oral convenience similar to Capecitabine
• Clinical equivalence shown in some colorectal cancer trials

Cons:

• Not FDA-approved in the United States
• Limited availability in U.S. pharmacies

Best for: Patients with access through international pharmacies or specific clinical scenarios where their oncologist recommends it.

Important: Only Your Oncologist Can Make the Switch

While it's helpful to know what alternatives exist, never switch medications on your own. Each of these drugs has different dosing, side effects, and drug interactions. Your oncologist will consider your specific cancer type, stage, prior treatments, kidney and liver function, and other factors before recommending a change.

If you're struggling to find Capecitabine, the first call should always be to your oncologist's office. They can help determine the best path forward and may be able to locate supply through channels not available to retail patients.

For more on availability, read How to Find Capecitabine in Stock Near You, or use Medfinder to search for pharmacies with Capecitabine in stock.

Final Thoughts

Running out of a chemotherapy drug is scary, but you have options. Intravenous 5-FU is the most direct backup since it's the same compound your body makes from Capecitabine. Lonsurf offers another oral option for specific cancer types. And your oncology team has dealt with these situations before — they know how to keep your treatment on track.

The key is to act quickly and communicate openly with your care team. Don't wait until you've taken your last pill to start looking for your next supply.